An increased expression of NPR3 in WAT of obese patients was associated with lower levels of bioavailable NPs and consequently to a progression of obesity and typical concomitant diseases, such as diabetes, hypertension, and liver steatosis [32, 37]. The gene discussed is NPR3; the disease is obesity disorder.